Russia repeats 91.4% efficacy rate in new COVID-19 vaccine data - developers

|
PrintFind an error? Report us
Russian developers published fresh trial results for their Sputnik V coronavirus vaccine on Monday based on new data, and said the shot had again been found to be 91.4% effective in providing protection from COVID-19.
More than 200,000 people have already been vaccinated against the disease as part of Russia's mass inoculation program, which began in September alongside a Moscow-based human trial of the shot.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""